OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
28
Results
Show all
Save search
Copy query
Show results for
Unknown
(28)
Publication Date
Release Date
2020
(5)
2015
(4)
2022
(3)
2019
(3)
2018
(3)
2025
(2)
2023
(2)
2021
(2)
2013
(2)
2016
(1)
2014
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia.
Not available
S-EPMC9278306
|
biostudies-literature
Cite
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse.
Not available
S-EPMC7362348
|
biostudies-literature
Cite
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Not available
S-EPMC10285011
|
biostudies-literature
Cite
A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Not available
S-EPMC8252033
|
biostudies-literature
Cite
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
Not available
S-EPMC3688062
|
biostudies-literature
Cite
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.
Not available
S-EPMC4134764
|
biostudies-literature
Cite
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial.
Not available
S-EPMC12547833
|
biostudies-literature
Cite
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
Not available
S-EPMC7001730
|
biostudies-literature
Cite
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Not available
S-EPMC10100228
|
biostudies-literature
Cite
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.
Not available
S-EPMC8714726
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
